株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の頭頸部癌市場:診断イメージング装置、内視鏡スクリーニング装置、生検スクリーニング検査、歯科診断法、地域別 - 成長、動向、予測

Head and Neck Cancer Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 390801
出版日 ページ情報 英文 120 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.80円で換算しております。
Back to Top
世界の頭頸部癌市場:診断イメージング装置、内視鏡スクリーニング装置、生検スクリーニング検査、歯科診断法、地域別 - 成長、動向、予測 Head and Neck Cancer Diagnostics Market - Growth, Trends, and Forecast (2020 - 2025)
出版日: 2020年02月01日 ページ情報: 英文 120 Pages
担当者のコメント
下記の日本語概要は、最新版レポートの内容と異なる場合があります。詳細はお問合せください。
概要

頭頸部癌は、世界で最も一般的な癌のひとつで、特に飲酒・喫煙の多い地域で顕著です。世界の頭頸部癌市場は、調査期間の2018年から2023年にかけて10.5%のCAGRで推移することが予測されています。

当レポートでは、世界の頭頸部癌市場を調査し、市場の概要、セグメント・地域別の市場動向、市場規模の推移と予測、成長要因・阻害要因ならびに市場機会・課題の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

  • 市場の定義

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 主な影響要因

第5章 市場の概要

  • 現在の市場シナリオ
  • ファイブフォース分析
    • 買い手の交渉力
    • 供給企業の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係

第6章 成長要因、阻害要因、市場機会、課題の分析(DROC)

  • 成長要因
    • 対象疾患の罹患率の上昇
    • 世界的な高齢者人口の増加
    • 政府および民間団体による取り組みの増加
  • 阻害要因
    • デジタル技術を用いたシステムの普及停滞
    • 先進国市場における医療機器への課税
  • 市場機会
  • 主な課題

第7章 世界の頭頸部癌市場:セグメント別

  • 診断イメージング装置別
    • PET(陽電子放出断層撮影)
    • CT(コンピュータ断層診断装置)
    • MRI(核磁気共鳴画像法)
  • 内視鏡スクリーニング装置別
    • 咽頭鏡
    • 喉頭鏡
    • 内視鏡
  • 生検スクリーニング検査別
    • 切開生検
    • 微細針吸引生検
    • ヒトパピローマウイルス(HPV)検査
  • 歯科診断法別
    • トルイジンブルー染色法
    • 酢酸法
    • ブラシ生検
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
    • 南米

第8章 競合情勢

  • 合併および買収分析
  • 合意・協力・提携
  • 新製品の発売

第9章 主要企業のプロファイル

  • Addent, Inc.
  • GE Healthcare
  • Identafi
  • Philips Healthcare
  • 島津製作所
  • Siemens Healthcare
  • Varian Medical Systems
  • Velscope VX

第10章 市場の将来展望

目次
Product Code: 49126

The head and neck cancer diagnostics market is expected to grow at a high rate. Some of the major trends driving the market are the increasing number of cases of target diseases, growing aging population that increased the prevalence of chronic diseases, increasing number of diagnostic procedures for head and neck cancer, and better healthcare initiatives by governments and various private organizations.

The increasing disposable incomes that lead to rise in the healthcare expenditure of people, rising demand for diagnostic imaging, advances in treatment modes, and incorporation of novel technologies in diagnostic equipment will further propel market growth during the forecast period.

Some of the restraining factors for this market includes the low adoption rate of digital technology-based systems, conventional CT and MRI scanners, excise duty imposed on sale of medical devices in mature markets, lack of trained professionals for operating the instruments, high cost associated with the treatment modes and lack of awareness among the people.

Key Market Trends

Diagnostic Imaging Equipment is Expected to Dominate the Market

Medical imaging is the technique and process of creating visual representations of the interior of a body for clinical analysis and medical intervention, as well as visual representation of the function of some organs or tissues (physiology). Head and neck cancer is a group of cancers that usually originate in the squamous cells that line the mouth, nose and throat. To confirm a diagnosis of cancer and determine if it has spread, head MRI, CT of the sinuses, head CT, panoramic dental x-ray, dental cone beam CT, PET/CT or chest imaging are some of the most common procedures.

Moreover, as per Gunnar Juliusson et al. report published in Acta Radiologica Open Journal 2019, the number of CT examinations per 1000 patients has increased from 51 in 2007 to 108 in 2017 in Europe. However this indicates that the more CT scans are being adopted and hence this is expected to positively impact the diagnostic imaging equipment market as well.

North America is Expected to Dominate the Head and Neck Cancer Diagnostics Market

According to the National Health Institute, the head and neck cancer accounts for approximately 4% of all cancers in the United States. This type of cancer is found to be more than twice as common among men as they are among women. The researchers also estimated that more than 65,000 men and women in the country have been diagnosed with head and neck cancer in 2017. Thus, this huge disease burden will help in the growth of the market.

The Epidemiology and End Results (SEER) Program estimated that 53,000 new cases of oral cavity and pharyngeal cancer occur in the United States in 2019, making up 3% of all new US cancer cases. The SEER Program also estimated that such cancer cases would account for 10,860 US deaths in the year, making up 1.8% of all cancer deaths. Thus, the growth in these programs has helped in the overall growth of the market. In addition, with the rise in the head and neck cancer in the United States, there is an increased demand for diagnostic imaging and new advancements and innovations are seen in the treatment models, which help in the growth of the overall market.

Hence, the increasing geriatric population worldwide, combined with government and private body initiatives are some of the other factors contributing to the growth of the market.

Competitive Landscape

Majority of the head and neck cancer diagnostics equipment are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in Incidences of Target Diseases
    • 4.2.2 Rise in Global Geriatric Population Levels
    • 4.2.3 Increasing Number of Diagnostic Procedures for Head and Neck Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Devices and Unfavourable Reimbursement Scenarios
    • 4.3.2 Dearth of Trained Professionals
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Diagnostic Method
    • 5.1.1 Diagnostic Imaging Equipment
    • 5.1.2 Endoscopy Screening Equipment
    • 5.1.3 Bioscopy Screening Tests
    • 5.1.4 Dental Diagnostic Methods
    • 5.1.5 Other Diagnostic Methods
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Diagnostic Centers
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Addent Inc
    • 6.1.2 GE Healthcare
    • 6.1.3 Identafi
    • 6.1.4 Philips Healthcare
    • 6.1.5 Shimadzu Corporation
    • 6.1.6 Siemens Healthineers
    • 6.1.7 Varian Medical Systems
    • 6.1.8 Apteryx Imaging Inc

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top